PBOVI promotes prostate cancer proliferation by promoting G1/Stransition

15Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Prostate cancer (PC) is one of the leading causes of cancer death in men, and thus, finding new regulators is critical for PC therapy. Prostate and breast cancer overexpressed 1 (PBOV1) is overexpressed in breast, prostate, and bladder cancers, as it is upregulated in the serum of patients with PC, but the role of PBOV1 in PC has not been studied. In this article, we found that PBOV1 was indeed overexpressed in PC cells; PBOV1 overexpression promoted cell proliferation and colony formation ability and arrested cell cycle in the G0/G1 phase and tumorigenicity ability in vitro, whereas knockdown of PBOV1 reduced these effects. Further analysis of PBOV1 overexpression inhibited cell cycle inhibitors, P21 and P27, and increased the phosphorylation level of Rb and cyclin D1 expression, suggesting that PBOV1 promoted cell proliferation through promoting G1/S transition.

Cite

CITATION STYLE

APA

Pan, T., Wu, R., Liu, B., Wen, H., Tu, Z., Guo, J., … Shen, G. (2016). PBOVI promotes prostate cancer proliferation by promoting G1/Stransition. OncoTargets and Therapy, 9, 787–795. https://doi.org/10.2147/OTT.S92682

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free